[Interest of ranitidine, a new H2 receptor antagonist in the treatment of Zollinger-Ellison syndrome (author's transl)].
D000328:Adult; D002927:Cimetidine / Q000009:adverse effects; D005663:Furans / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D011899:Ranitidine; D013270:Stomach / Q000187:drug effects; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy*
D005663:Furans; D006635:Histamine H2 Antagonists; D002927:Cimetidine; D011899:Ranitidine
Intérêt d'un nouvel antagoniste des récepteurs H2, la ranitidine, dans le traitement du syndrome de Zollinger-Ellison.